© University of Kent - Contact | Feedback | Legal | Cookies
The University of Kent, Canterbury, Kent, CT2 7NZ, T +44 (0)1227 764000
IP and licensing
New technologies, processes and knowledge regularly emerge from the University of Kent's impressive research portfolio. This intellectual property provides opportunities for collaboration, and licensing of new technologies in numerous fields from health, biosciences and electronics to transportation.
Some of our on-going licensing deals include:
Delta Biotechnology (now Novozymes Biopharma) licensed an improved biopharmaceutical production technology from the School of Biosciences; the first major license from the yeast expression group for application in high yield protein manufacture. A follow up license was secured with US Company BioRexis Inc (subsequently acquired by Pfizer) for use in the production of its unique transferrin tagged proteins.
Harada Industries (Europe) licensed technology from the Department of Electronics for a novel antenna. This technology was subsequently used in Volvo vehicle manufacturing and was incorporated into the top-of-the-range XC90.
If intellectual property within the University of Kent's portfolio has a benefit to your business, please get in touch.
Intellectual Property available for licensing
Examples of patented Intellectual Property available for licensing:
Imaging
- Imaging methods for use in Optical Coherence Tomography and Spectral Interferometry.
- Methods for extending the capability of digital cameras to allow them to function as a cost effective fundus camera, a microscope or an en face OCT device
Monitoring, security and biometrics
- Methods for the fabrication of novel RFID tags and allowing shielding of selective RFID frequencies
- Methodologies to generate template free biometric codes
Telecommunications
- An optical frequency comb generator for generating from first and second signal sources a plurality of signals with fixed frequency spacing derived from the second signal source frequency
Health and biotechnology
- Chemical inhibitors of soluble adenylyl cyclase (co-owned with Cornell University)
- Methods for modulating quorum sensing in bacteria
- Methods for the production of correctly folded recombinant proteins in yeast (co-owned with Merck)
Example of reagents available under Material Transfer Agreements:
- Materials for the acetylation of recombinant proteins in a bacterial host. Known as pACYCduet-naa20+-naa25+ (pNatB) plasmid (described in PLoS One. 5: e15801)
- Variety of drug resistant cancer cell lines (examples described in Cell Death & Disease (2011) 2, e243; doi:10.1038/cddis.2011.129 )
If you are interested in finding out more about any of these licensing opportunities, please get in touch with the business development team.